Ofloxacin
Who holds supplier records for Ofloxacin? 9 organisations hold a current record for Ofloxacin: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), Spain (1), United States (1), Japan (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ofloxacin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ofloxacin
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ofloxacin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- QUIMICA SINTETICA SASpainCEP Company GMP cert on recordActive DMF 14767 · latest filing Mar 2000
- CAMBREX CHARLES CITY INCUnited StatesActive DMF 14928 · latest filing Jun 2000
- GLOBELA INDUSTRIES PRIVATE LTDActive DMF 44774 · latest filing Sept 2026
- MAHIMA LIFE SCIENCES PRIVATE LTDIndiaActive DMF 27887 · latest filing Dec 2013
- Neuland Laboratories LimitedIndiaActive DMF 15433 · latest filing May 2001
- TURTLE PHARMA PRIVATE LTDIndiaActive DMF 33250 · latest filing Oct 2018
- JapanCEP Company GMP cert on record
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordInactive DMF 14240 · latest filing Jun 1999
- Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Ofloxacin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. Jinhua | CN | CEP 2021-213 - Rev 02 Ofloxacin, Process H | Oct 2026 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2000-106 - Rev 10 Ofloxacin | Feb 2025 | — |
| DAIICHI SANKYO CO., LTD. Tokyo | JP | CEP 2003-210 - Rev 04 Ofloxacin | Dec 2024 | — |
| QUIMICA SINTETICA S.A. Alcala De Henares | ES | CEP 2000-134 - Rev 07 Ofloxacin | Oct 2023 | Inspected Apr 2025 Spain |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Ofloxacin are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- KUNSHAN DOUBLE CRANE PHARMACEUTICAL CO LTDInactive DMF 17308 · filed Apr 2004
- India · Inactive DMF 16753 · filed Aug 2003
- United States · Inactive DMF 10922 · filed May 1994
Overview
Ofloxacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4).
Chemical identity
- IUPAC name
- 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
- Canonical SMILES
- CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
- InChIKey
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N
- Synonyms
- DL-8280, Exocin, Floxin, Floxin otic, HOE 280, HOE-280, J01MA01, NSC-727071, NSC-758178, Ocuflox, Ofloxacin, Ofloxacine
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Quinolone Antimicrobial
- Chemical structure
- Quinolones
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ofloxacin?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Ofloxacin: QUIMICA SINTETICA SA (Spain), CAMBREX CHARLES CITY INC (United States), GLOBELA INDUSTRIES PRIVATE LTD, MAHIMA LIFE SCIENCES PRIVATE LTD (India), Neuland Laboratories Limited (India), TURTLE PHARMA PRIVATE LTD (India), Daiichi Sankyo Co., Ltd. (Japan) and Sun Pharmaceutical Industries Limited (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ofloxacin Drug Master Files are active?
QUIMICA SINTETICA SA (DMF 14767), CAMBREX CHARLES CITY INC (DMF 14928), GLOBELA INDUSTRIES PRIVATE LTD (DMF 44774), MAHIMA LIFE SCIENCES PRIVATE LTD (DMF 27887), Neuland Laboratories Limited (DMF 15433) and TURTLE PHARMA PRIVATE LTD (DMF 33250). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ofloxacin records mean?
3 organisations have only inactive Type II DMFs for Ofloxacin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Ofloxacin have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Ofloxacin on the EDQM register, including ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. Jinhua (CN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), DAIICHI SANKYO CO., LTD. Tokyo (JP) and QUIMICA SINTETICA S.A. Alcala De Henares (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Ofloxacin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ofloxacin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.